Description
Objectives
Target Audience
Accreditation
Faculty
Disclosures
Description

Magnetic resonance imaging (MRI) has become an essential noninvasive tool for the detection, staging, and management of breast cancer, with advances in magnet strength, dedicated breast coils, pulse sequences, contrast agents, and optimized protocols significantly improving diagnostic performance. Breast MRI is increasingly utilized for screening patients at elevated risk, assessing disease extent in newly diagnosed cancer, and evaluating response to therapy. Although evidence-based guidelines from the American College of Radiology outline best practices for breast MRI and MRI-guided interventions, gaps remain in consistent application across clinical settings. This enduring monograph addresses these gaps by providing education to support radiologists and MRI technologists, in the optimal, guideline-informed use of contemporary breast MRI techniques.

Objectives

At the completion of this activity, the participant will be able to:

1. Review requirements for breast MRI, including techniques used to optimize breast magnetic resonance (MR) protocols
2. Implement 1.5T and 3T breast MR protocols that provide optimal visualization of breast cancers
3. Describe strategies for minimizing gadolinium exposure during breast MRI
4. Discuss breast MR image interpretation including the use of computer-aided evaluation systems

Target Audience

The content of this contrast enhanced MRI program is intended for radiologists and other physicians, technologists, facility managers, researchers, and other healthcare professionals.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 03/11/2026 | Expiration Date 03/11/2027

Faculty and Planner Disclosures:

As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Roberta Strigel, MD, MS, FSBI

Professor, Breast Imaging and Intervention
Director, Breast MRI
Breast Imaging Fellowship Director
Departments of Radiology and Medical Physics
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

Margarita L. Zuley, MD, FACR, FSBI

Professor and Vice Chair, Quality and Strategic Development
Chief, Division of Breast Imaging
Department of Radiology
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Disclosures

Margarita L. Zuley, MD, FACR, FSBI

Hologic Inc., Principal investigator on institutional grant
Bayer Inc., Consultant
Bracco Inc., Principal investigator on institutional grant

Roberta Strigel, MD, MS, FSBI

GE HealthCare, Institutional MRI research support

Monograph only –  Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

Magnetic resonance imaging (MRI) has become an essential noninvasive tool for the detection, staging, and management of breast cancer, with advances in magnet strength, dedicated breast coils, pulse sequences, contrast agents, and optimized protocols significantly improving diagnostic performance. Breast MRI is increasingly utilized for screening patients at elevated risk, assessing disease extent in newly diagnosed cancer, and evaluating response to therapy. Although evidence-based guidelines from the American College of Radiology outline best practices for breast MRI and MRI-guided interventions, gaps remain in consistent application across clinical settings. This enduring monograph addresses these gaps by providing education to support radiologists and MRI technologists, in the optimal, guideline-informed use of contemporary breast MRI techniques.

Objectives

At the completion of this activity, the participant will be able to:

1. Review requirements for breast MRI, including techniques used to optimize breast magnetic resonance (MR) protocols
2. Implement 1.5T and 3T breast MR protocols that provide optimal visualization of breast cancers
3. Describe strategies for minimizing gadolinium exposure during breast MRI
4. Discuss breast MR image interpretation including the use of computer-aided evaluation systems

Target Audience

The content of this contrast enhanced MRI program is intended for radiologists and other physicians, technologists, facility managers, researchers, and other healthcare professionals.

Accreditation

This program has been applied for .75 hours of Category A CE credit as designated by the International Society for MR Radiographers & Technologists (ISMRT) RCEEM. Additionally, this activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 03/11/2026 | Expiration Date 03/11/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Roberta Strigel, MD, MS, FSBI

Professor, Breast Imaging and Intervention
Director, Breast MRI
Breast Imaging Fellowship Director
Departments of Radiology and Medical Physics
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

Margarita L. Zuley, MD, FACR, FSBI

Professor and Vice Chair, Quality and Strategic Development
Chief, Division of Breast Imaging
Department of Radiology
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Monograph only –  Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

Magnetic resonance (MR) imaging and MR angiography continue to advance through improvements in magnet strength, coil design, pulse sequences, contrast agents, and imaging protocols, expanding their role in cardiovascular, neurologic, and body imaging. While these innovations enhance diagnostic accuracy and procedural guidance, gaps remain in clinician education related to MR safety and contrast use, including nephrogenic systemic fibrosis (NSF), acute adverse reactions, and gadolinium retention. Historically, these topics have not been consistently incorporated into core training, and available resources often lack practical, implementation-focused guidance. This enduring monograph addresses these gaps by providing evidence-based education to support safe, informed, and effective use of contemporary MR technologies in clinical practice.

Objectives

At the completion of this activity, the participant will be able to:

1. Describe 1.5T and 3T MR protocols that provide optimal visualization of difficult-to-identify abnormalities and lesions
2. Review where and when gadolinium-based contrast agents (GBCAs), including high-relaxivity agents are most appropriate in terms of visualization of lesions and/or reducing the incidence of contrast-related adverse events
3. Discuss possible acute and chronic adverse reactions to GBCAs including anaphylactoid reactions, nephrogenic systemic fibrosis (NSF), and gadolinium retention

Target Audience

The content of this contrast enhanced MRI program is intended for healthcare professionals who work in the MRI environment. These individuals include MRI technologists, imaging nurses, MRI researchers, and others.

Accreditation

This program has been approved for 2.25 hours of Category A CE credit as designated by the International Society for MR Radiographers & Technologists (ISMRT) RCEEM. Additionally, this activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 03/11/2026 | Expiration Date 03/11/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Thomas M. Grist, MD, FACR

John Juhl Professor of Radiology and Medical Physics
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

Monograph only –  Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “Basics of Bubbles: CEUS for Echocardiography and Implications for your lab 2nd edition” discusses a practical overview of UEA imaging principles, understanding UEA quantification, and reviewing the developing technology with potential clinical applications tailored to individual patients. The purpose of this webinar is to provide Sonographers, Imaging Nurses, Administrators, Researchers, and Others with current clinical data to make informed decisions in their clinical settings.

Objectives

• Review the basics of UEAs and the brands of UEA available in the United States
• Discuss indications for UEA use and evidence base for efficacy in practice
• Understand the best practices for the use of UEAs in echocardiography laboratories and the role of decision aides

Target Audience

The content of this SDMS CME symposium is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This SDMS CME activity has been planned and submitted for approval of .75 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 06/24/2026 | Expiration Date 06/24/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its webinar activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Jordan B. Strom, MD, MSc,
FACC, FASE

Medical Director, Echocardiography Laboratory,
Division of Cardiovascular Medicine,
Beth Israel Deaconess Medical Center
Associate Professor of Medicine, Harvard Medical School,
Boston, MA

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Disclosures
Description

Ultrasound Enhancing Agents (UEAs) play an important role in improving image quality and diagnostic confidence in echocardiography. Although hypersensitivity reactions to UEAs are extremely rare, echocardiography laboratory staff should be prepared to recognize and appropriately manage these events to support patient safety. This activity will review the clinical presentation of hypersensitivity reactions and discuss how to differentiate them from underlying cardiac symptoms that may present similarly. Practical considerations for patient prescreening and implementation of appropriate response protocols within the echocardiography laboratory will also be discussed.

Objectives

After completing this activity, participants should be better able to:

• Discuss the incidence of adverse reactions to ultrasound-enhancing agents (UEAs)
• Differentiate mild hypersensitivity reactions from more serious anaphylactic reactions as well as underlying cardiac symptomology that could mimic UEA hypersensitivity reactions
• Review emergency protocols to effectively manage patients with adverse reactions to UEAs
• Summarize echo staff’s role and responsibilities in optimizing patient safety in the echo lab

Target Audience

The content of this CME / SDMS CME webinar is intended for healthcare professionals including physicians, sonographers, imaging nurses, administrators, researchers, and others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 02/15/2026 | Expiration Date 02/15/2027

Faculty and Planner Disclosures:

As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Jordan B. Strom, MD, MSc, FACC, FASE

Associate Professor of Medicine, Harvard Medical School
Director, Echocardiography Laboratory
Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center
Section Head, Cardiovascular Imaging Research
Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology
Boston, Massachusetts

Jessica Stout, BS, RDCS, ACS, FASE

Sonographer and Technical Director
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Disclosures

Dr. Strom Disclosures:

1. Edwards Lifesciences – consulting, grant support
2. Ultromics – Scientific Advisory Board
3. HeartSciences – Scientific Advisory Board
4. Bracco Diagnostics – consulting, grant support
5. Anumana – grant support
6. General Electric Healthcare – consulting, scientific advisory board
7. Phillips Healthcare – grant support, consulting
8. ICUS – fiduciary (secretary of board of directors)
9. NIH/NHLBI – Grant support (1R01HL169517, 1R01AG063937, 1R01HL173998)
10. EchoIQ – grant support, scientific advisory board, equity (< 1% of shares)
11. Pfizer – Clinical Endpoint Committee
12. EVERSANA – Consulting, Grant support
13. Bristol Myers Squibb – Consulting
14. Viz.AI – grant support
15. Alnyam – scientific advisory board
16. Ultrasight – scientific advisory board
17. Agitated Solutions – Clinical Endpoint Committee

Dr. Strom reports research grants from the National Heart, Lung, and Blood Institute (1R01HL169517, 1R01HL173998), Edwards Lifesciences, EchoIQ, Anumana, Philips Healthcare, Viz.ai, EVERSANA Lifesciences; consulting for Bracco Diagnostics, Edwards Lifesciences, Philips Healthcare, Ultrasight, General Electric Healthcare, and EVERSANA Lifesciences; clinical endpoint committee for Pfizer and Agitated Solutions, and is a member of the scientific advisory boards for Ultromics, HeartSciences, Bristol Myers Squibb, Alnyam, and EchoIQ.

Jessica Stout Disclosures:

• GE Healthcare – Consultant
• Bracco Diagnostics – Speakers Bureau

Description/Statement of Need
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description/Statement of Need

There is a continuing need to provide high-quality, timely, and clinically relevant cardiovascular education. This 2nd Edition of “Microbubbles in Practice” has been updated with new content to reflect the latest developments in the field. In this program, we provide an overview of ultrasound enhancing agents (UEAs) and the types of UEAs currently available in the United States. We review the historical and updated safety data on UEAs, discuss contemporary approaches to managing adverse reactions, and evaluate current indications for UEA use along with the evolving evidence base supporting their efficacy in clinical practice. These updates will equip physicians and sonographers with the most current information and data to make well-informed decisions in their clinical settings.

Objectives

1. Provide an overview of UEAs and the brands of UEA available in the United States
2. Review the historical safety data on UEAs and the approach towards adverse reactions
3. Discuss indications for UEA use and evidence base for efficacy in practice
4. Review the efficacy and cost-effectiveness of UEAs in the ED and ICU
5. Understand the best practices for use of UEAs in echocardiography laboratories and the role of decision aids
6. Go over the billing/coding for UEA in echocardiography

Target Audience

The content of this webinar is intended for healthcare professionals including cardiologists, sonographers, imaging nurses, administrators, researchers, and others.

Accreditation

This SDMS CME activity has been planned and submitted for approval of .75 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 04/27/2026 | Expiration Date 04/27/2027

Faculty and Planner Disclosures:

As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jordan Strom, MD, MSc, FACC, FASE

• Philips Healthcare – Consultant
• Edwards Lifesciences – Grant Funding

Faculty

Jordan B. Strom, MD, MSc, FACC, FASE

Director, Echocardiography Laboratory, Division of Cardiovascular Medicine,
Beth Israel Deaconess Medical Center Section Head,
Cardiovascular Imaging Research,
Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology
Associate Professor of Medicine,
Harvard Medical School
Boston, MA

Video only –  Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Description/Statement of Need
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description/Statement of Need

There is a continuing need to provide high-quality, timely, and clinically relevant cardiovascular education. This 2nd Edition of “Microbubbles in Practice” has been updated with new content to reflect the latest developments in the field. In this program, we provide an overview of ultrasound enhancing agents (UEAs) and the types of UEAs currently available in the United States. We review the historical and updated safety data on UEAs, discuss contemporary approaches to managing adverse reactions, and evaluate current indications for UEA use along with the evolving evidence base supporting their efficacy in clinical practice. These updates will equip physicians and sonographers with the most current information and data to make well-informed decisions in their clinical settings.

Objectives

1. Provide an overview of UEAs and the brands of UEA available in the United States
2. Review the historical safety data on UEAs and the approach towards adverse reactions
3. Discuss indications for UEA use and evidence base for efficacy in practice
4. Review the efficacy and cost-effectiveness of UEAs in the ED and ICU
5. Understand the best practices for use of UEAs in echocardiography laboratories and the role of decision aids
6. Go over the billing/coding for UEA in echocardiography

Target Audience

The content of this webinar is intended for healthcare professionals including cardiologists, sonographers, imaging nurses, administrators, researchers, and others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 04/27/2026 | Expiration Date 04/27/2027

Faculty and Planner Disclosures:

As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jordan Strom, MD, MSc, FACC, FASE

• Philips Healthcare – Consultant
• Edwards Lifesciences – Grant Funding

Faculty

Jordan B. Strom, MD, MSc, FACC, FASE

Director, Echocardiography Laboratory,
Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center
Section Head, Cardiovascular Imaging Research
Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Video only –  Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Description
Objectives
Target Audience
Accreditation
Faculty
Disclosures
Description

Ultrasound Enhancing Agents (UEAs) play an important role in improving image quality and diagnostic confidence in echocardiography. Although hypersensitivity reactions to UEAs are extremely rare, echocardiography laboratory staff should be prepared to recognize and appropriately manage these events to support patient safety. This activity will review the clinical presentation of hypersensitivity reactions and discuss how to differentiate them from underlying cardiac symptoms that may present similarly. Practical considerations for patient prescreening and implementation of appropriate response protocols within the echocardiography laboratory will also be discussed.

Objectives

After completing this activity, participants should be better able to:

• Discuss the incidence of adverse reactions to ultrasound-enhancing agents (UEAs)
• Differentiate mild hypersensitivity reactions from more serious anaphylactic reactions as well as underlying cardiac symptomology that could mimic UEA hypersensitivity reactions
• Review emergency protocols to effectively manage patients with adverse reactions to UEAs
• Summarize echo staff’s role and responsibilities in optimizing patient safety in the echo lab

Target Audience

The content of this CME / SDMS CME webinar is intended for healthcare professionals including physicians, sonographers, imaging nurses, administrators, researchers, and others.

Accreditation

This SDMS CME activity has been planned and submitted for approval of 1.00 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 02/15/2026 | Expiration Date 02/15/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CE activity. The planner has nothing to disclose.

Faculty

Jordan B. Strom, MD, MSc, FACC, FASE

Associate Professor of Medicine, Harvard Medical School
Director, Echocardiography Laboratory
Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center
Section Head, Cardiovascular Imaging Research
Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology
Boston, Massachusetts

Jessica Stout, BS, RDCS, ACS, FASE

Sonographer and Technical Director
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Disclosures

Dr. Strom Disclosures:

1. Edwards Lifesciences – consulting, grant support
2. Ultromics – Scientific Advisory Board
3. HeartSciences – Scientific Advisory Board
4. Bracco Diagnostics – consulting, grant support
5. Anumana – grant support
6. General Electric Healthcare – consulting, scientific advisory board
7. Phillips Healthcare – grant support, consulting
8. ICUS – fiduciary (secretary of board of directors)
9. NIH/NHLBI – Grant support (1R01HL169517, 1R01AG063937, 1R01HL173998)
10. EchoIQ – grant support, scientific advisory board, equity (< 1% of shares)
11. Pfizer – Clinical Endpoint Committee
12. EVERSANA – Consulting, Grant support
13. Bristol Myers Squibb – Consulting
14. Viz.AI – grant support
15. Alnyam – scientific advisory board
16. Ultrasight – scientific advisory board
17. Agitated Solutions – Clinical Endpoint Committee

Dr. Strom reports research grants from the National Heart, Lung, and Blood Institute (1R01HL169517, 1R01HL173998), Edwards Lifesciences, EchoIQ, Anumana, Philips Healthcare, Viz.ai, EVERSANA Lifesciences; consulting for Bracco Diagnostics, Edwards Lifesciences, Philips Healthcare, Ultrasight, General Electric Healthcare, and EVERSANA Lifesciences; clinical endpoint committee for Pfizer and Agitated Solutions, and is a member of the scientific advisory boards for Ultromics, HeartSciences, Bristol Myers Squibb, Alnyam, and EchoIQ.

Jessica Stout Disclosures:

• GE Healthcare – Consultant
• Bracco Diagnostics – Speakers Bureau

Description

This video is designed to be used for annual MR safety training specifically for the radiologist who oversees MRI.

Accreditation

There is no accreditation for this video.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This enduring monograph provides pharmacists with an evidence-based review of gadolinium-based contrast agents (GBCAs) used in magnetic resonance imaging, with emphasis on differences in relaxivity, dosing, safety profiles, and clinical performance. The activity supports pharmacists involved in formulary management and medication safety by highlighting how contrast agent selection can impact diagnostic quality, patient exposure to gadolinium, and overall value of care.

Objectives

At the completion of this activity, the participant will be able to

1. Describe the key differences among gadolinium-based contrast agents (GBCAs), including molecular structure, relaxivity, dosing, and safety profiles that influence MRI diagnostic performance.
2. Explain how GBCA selection impacts patient safety, including considerations related to gadolinium exposure, renal function, and use in patients requiring repeated contrast-enhanced MRI examinations.
3. Discuss the role of the pharmacist in evaluating MRI contrast agents for formulary inclusion, including considerations of efficacy, safety, sustainability, and overall value within the health-system practice.

Target Audience

The target audience for this paper consists primarily of hospital and clinic pharmacists, specifically those involved in drug selection, formulary management, and the acquisition of diagnostic imaging agents.

Accreditation

This activity is approved for 1.0 contact hour by the Washington State Pharmacy Association in joint providership with Northwest Imaging Forums, Inc. UNIVERSAL ACTIVITY NUMBER (UAN): 0130-9999-26-028-H01-P

Release Date: 01/23/2026 | Expiration Date 01/23/2027

Northwest Imaging Forums, Inc is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.

Faculty and Planner Disclosures:
As an accredited provider of continuing pharmacy education, it is the policy of Northwest Imaging Forums, Inc. (NWIF), in joint providership with the Washington State Pharmacy Association, to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CPE activity. The planner has nothing to disclose.

Faculty

Brandon Ferlas, PharmD, MBA-HA, MS, FACHE

Director of Pharmacy and Imaging Services
CommonSpirit Health Mountain Region
Denver, CO

Alessandro Furlan, MD, MMM, MRMD, FESGAR, FSAR

Professor of Radiology | Chief of Abdominal Imaging Section
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, PA

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This enduring monograph provides technologists, imaging nurses, and administrators with an evidence-based review of gadolinium-based contrast agents (GBCAs) used in magnetic resonance imaging, with emphasis on differences in relaxivity, dosing, safety profiles, and clinical performance. The activity supports imaging professionals involved in patient care and contrast administration by highlighting how contrast agent selection can impact diagnostic quality, patient exposure to gadolinium, and overall value of care.

Objectives

At the completion of this activity, the participant will be able to:

1. Describe the key differences among gadolinium-based contrast agents (GBCAs), including molecular structure, relaxivity, dosing, and safety profiles that influence MRI diagnostic performance.
2. Explain how GBCA selection impacts patient safety, including considerations related to gadolinium exposure, renal function, and use in patients requiring repeated contrast-enhanced MRI examinations.
3. Discuss the role of the pharmacist in evaluating MRI contrast agents for formulary inclusion, including considerations of efficacy, safety, sustainability, and overall value within health-system practice.

Target Audience

The content of this CE  webinar is intended for Technologists, Imaging Nurses, Administrators, Researchers, and other healthcare professionals.

Accreditation

This program has been approved for 1.0 hour of Category A CE credit as designated by the International Society for MR Radiographers & Technologists (ISMRT) RCEEM. Additionally, this activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 01/23/2026 | Expiration Date 01/23/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Brandon Ferlas, PharmD, MBA-HA, MS, FACHE

Director of Pharmacy and Imaging Services
CommonSpirit Health Mountain Region
Denver, CO

Alessandro Furlan, MD, MMM, MRMD, FESGAR, FSAR

Professor of Radiology | Chief of Abdominal Imaging Section
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, PA

Description
Objectives
Target Audience
Accreditation
Faculty
Description

Echocardiography is an important imaging modality for quantitative and qualitative evaluation of cardiac anatomy, physiology, and function. It has the proven advantages of providing dynamic, real-time imaging without exposing patients to ionizing radiation. The use of contrast during echocardiography, otherwise referred to as CE echocardiography, provides increased visualization of cardiac structures and blood flow.

For the full potential of CE echocardiography to be realized in clinical practice, sonographers need to become well versed in contrast-specific machine settings, software utilization, and contrast administration techniques. In addition, sonographers need to be able to troubleshoot why certain images may be suboptimal and how to adjust machine, software, and/or contrast settings to improve their performance in practice and thus the diagnostic quality of the examinations they perform.

Objectives

After completing this activity, participants should be better able to:

• Discuss accepted indications, applications, and techniques for CE echocardiography
• Review contrast-specific settings and protocols used during CE echocardiography
• Describe and identify suboptimal images and techniques, and review ways in which improved protocols, machine settings, and/or UEA administration can help remedy them

Target Audience

This activity is designed for sonographers interested in becoming actively involved and thus fluent in contrast-enhanced (CE) echocardiography.

Accreditation

This SDMS CME activity has been planned and submitted for approval of .5 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 02/15/2026 | Expiration Date 02/15/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its webinar activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Kevin Darville, BS, RDCS (AE, PE), RVT, ACS, CEP

Director of Cardiovascular Imaging
University Medical Center
Texas Tech University Health Sciences Center
Lubbock, Texas

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

Echocardiography is an important imaging modality for quantitative and qualitative evaluation of cardiac anatomy, physiology, and function. It has the proven advantages of providing dynamic, real-time imaging without exposing patients to ionizing radiation. The use of contrast during echocardiography, otherwise referred to as CE echocardiography, provides increased visualization of cardiac structures and blood flow. For the full potential of CE echocardiography to be realized within an echocardiography lab, protocols and procedures must be put into place that optimize workflow and staff training. Additionally, sonographers need to become familiar with UEA administration techniques and different types of venous access devices they may encounter in their practice.

Objectives

After completing this activity, participants should be better able to:

• Describe indications and techniques for CE echocardiography
• Summarize UEA administration techniques
• Discuss methods to improve the accessibility to UEAs and enhance workflow efficiencies in the echo lab

Target Audience

This activity is designed for sonographers interested in becoming actively involved and thus fluent in contrast-enhanced (CE) echocardiography.

Accreditation

This SDMS CME activity has been planned and submitted for approval of .5 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 02/15/2026 | Expiration Date 02/15/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its webinar activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Yvette Carvallo, RDCS, RVS, FASE

Lead Cardiovascular Technologist
Atlantic HealthCare System
Overlook Medical Center
Summit, New Jersey

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Target Audience
Objectives
Accreditation
Faculty
Description

Incidental findings on CT and MR images can play an important role in patient care, yet they are often overlooked or misunderstood. For technologists, recognizing the significance of these findings and understanding how imaging techniques, protocols, and AI applications can help identify and optimize them is essential. This program will explore how technologists can contribute to improving image quality, supporting diagnostic accuracy, and enhancing communication within the healthcare team when incidental findings are present.

Target Audience

The content of this CE  webinar is intended for Technologists, Imaging Nurses, Administrators, Researchers, and other healthcare professionals.

Objectives

After completing this activity, participants should be better able to:

• Understand the importance of incidental findings at CT and MR, both positive and negative aspects.
• Learn ways that we can take advantage of the additional information at CT and MR beyond the study indication.
• Understand how AI applications can further enhance our ability to opportunistically leverage incidental imaging findings.

Accreditation

This program has been approved for .75 hour of Category A CE credit as designated by the Society for MR Radiographers & Technologists (SMRT) RCEEM. Additionally, this activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 01/05/2026 | Expiration Date 01/05/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Perry J. Pickhardt, MD

Chief, Gastrointestinal Imaging
Medical Director of Oncological Imaging,
UW Carbone Cancer Center,
Madison, Wisconsin

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar will address the ongoing challenge of colorectal cancer (CRC), the second leading cause of cancer-related death in the United States, and the continued gap in screening adherence. Early detection and removal of precancerous lesions significantly reduce mortality, highlighting the importance of accessible screening strategies. While optical colonoscopy remains the most widely used visual modality, its invasive nature may limit patient participation. This session will explore Computed Tomography Colonography (CTC) as a noninvasive, efficient alternative that may improve screening uptake and expand access to effective CRC detection.

Objectives

After completing this activity, participants should be better able to:

• Review current guidelines and recommendations for CRC screening
• Discuss the relative advantages and disadvantages of different CRC screening methods—with a focus on comparing OC vs. CTC
• Describe CTC procedures and summarize how to implement a successful CRC screening program

Target Audience

The content of this CE webinar is intended for technologists and other healthcare professionals involved with CRC screening.

Accreditation

This activity has been approved for 1.0 hour of Category A CE Credit by The International Society for MR Radiographers & Technologists (ISMRT) Recognized Continuing Education Evaluation Mechanism (RCEEM). This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a live seminar/meeting or self-learning activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 07/28/2025 | Expiration Date 07/28/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CE activity. The planner has nothing to disclose.

Faculty

Judy Yee, MD, FACR

Professor and University Chair
Department of Radiology
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, New York

Kevin J. Chang, MD, FACR, FSAR

Director of MRI
Department of Radiology
Associate Professor of Radiology
Boston University School of Medicine
Boston, Massachusetts
Adjunct Associate Professor of Diagnostic Imaging
The Warren Alpert Medical School of Brown University
Providence, Rhode Island

Perry J. Pickhardt, MD

Professor of Radiology
Chief, Gastrointestinal Imaging
University of Wisconsin
School of Medicine & Public Health
Madison, Wisconsin

Description
Objectives
Target Audience
Accreditation
Faculty
Description

The risk of developing a urinary tract infection (UTI) during childhood is approximately 8% for girls and 2% for boys. Many of these children afflicted by recurrent UTIs have VUR. Children with VUR are at risk of renal scarring. This scarring can cause serious sequelae as these children grow into adulthood, including renal hypertension, proteinuria, and end-stage renal disease. The negative health impacts of VUR can be successfully ameliorated by prompt diagnosis, allowing for early  management with antibiotic prophylaxis to prevent UTIs and surgical interventions in more severe cases.

Currently, it is recommended that children with recurrent UTIs undergo diagnostic imaging to detect and/or confirm VUR. Three imaging modalities are currently available and include VCUG, DRNC, and ceVUS. Many children, once diagnosed with VUR, may require serial imaging to guide treatment; therefore, the safety and cost of the imaging modality are important. While ceVUS is perhaps the least utilized of the three above-mentioned modalities in the United States, it has a distinct advantage compared to both VCUG and DRNC because it does not expose children to ionizing radiation.

Objectives

After completing this activity, participants should be better able to:

• Review the epidemiology and potential consequences of VUR in pediatric patients.
• Summarize indications, practice guidelines, and recommendations demonstrating the diagnostic utility and safety of ceVUS for the diagnosis of VUR.
• Describe the diagnostic efficacy of ceVUS compared with voiding cystourethrography (VCUG) and direct radionuclide cystography (DRNC).

Target Audience

This activity is designed for pediatric radiologists, pediatric urologists, sonographers, and other healthcare professionals to help them better understand the indications, applications, potential benefits, and technical considerations in performing contrast-enhanced voiding urosonography (ceVUS) for the evaluation of vesicoureteral reflux (VUR) in pediatric patients.

Accreditation

This SDMS CME activity has been planned and submitted for approval of 1.00 hour of SDMS CME Credit Category AB by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 07/14/2025 | Expiration Date 07/14/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its webinar activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Dana A. Weiss, MD

Assistant Professor of Urology in Surgery Attending Pediatric Urologist, Division of Urology Children’s Hospital of Philadelphia
Perelman School of Medicine, University of Pennsylvania Philadelphia, Pennsylvania

Susan J. Back, MD, FAAP

Assistant Professor of Radiology
Director, Section of Genitourinary Imaging Director, Center for Pediatric Contrast Ultrasound,
Division of Body Imaging Children’s Hospital of Philadelphia
Perelman School of Medicine, University of Pennsylvania Philadelphia, Pennsylvania

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

Urinary tract infections (UTIs) are common in young children. It has been estimated that up to 7% of girls and 2% of boys will have a UTI in the first 6 years of life. Many of these children with recurrent UTIs have VUR. Children with VUR are at risk of renal scarring. This scarring can cause serious sequelae as these children grow into adulthood, including renal hypertension, proteinuria, and end-stage renal disease. The negative health impacts of VUR can be successfully ameliorated by prompt diagnosis, allowing for early management with antibiotic prophylaxis to prevent UTIs, and surgical interventions in more severe cases

Currently, recommendations are that children with febrile or recurrent UTIs undergo diagnostic imaging to evaluate for the presence of VUR. Three imaging modalities are currently available for VUR detection: voiding cystourethrography (VCUG), direct radionuclide cystography (DRNC), and contrast-enhanced voiding ultrasonography (CE-VUS). Many children, once diagnosed with VUR, may require serial imaging to guide treatment; therefore, the safety and cost of the imaging modality are important considerations. CE-VUS, widely used for decades primarily in Europe, was recently introduced in the United States. CE-VUS has high diagnostic accuracy in detecting reflux and does not expose children to ionizing radiation

Objectives

After completing this activity, participants should be better able to:

• Describe indications and accepted uses of CEUS of the kidneys, bladder, and urinary tract
• Summarize practice guidelines, recommendations, and clinical trials demonstrating the clinical utility of CEUS
• Review physicochemical, acoustic, and pharmacodynamics/pharmacokinetic characteristics of ultrasound contrast
  agents (UCAs)

Target Audience

This activity is designed for pediatric radiologists, pediatric urologists, sonographers, nurses, and other healthcare providers involved with imaging of the urinary tract in pediatric patients with known or suspected vesicoureteric reflux (VUR) to help them better understand the indications, applications, and potential benefits of utilizing contrast-enhanced ultrasound (CEUS) for detecting known or suspected diseases and abnormalities of the kidneys, bladder, and urinary tract.

Accreditation

This SDMS CME activity has been planned and submitted for approval of 1.00 hour of SDMS CME Credit Category AB by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 07/14/2025 | Expiration Date 07/14/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its webinar activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Richard G. Barr, MD, PhD

Professor of Radiology
Northeast Ohio Medical University
Director, Southwoods Imaging
Department of Radiology
Surgical Hospital at Southwoods
Youngstown, Ohio

Aikaterini Ntoulia, MD, PhD

Department of Radiology
The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

PDF Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

Contrast-enhanced ultrasound (CEUS) of the abdomen is currently an underutilized imaging modality in the United States, although it is a well-established, noninvasive, real-time imaging technique for evaluating known or suspected abdominal pathology of the liver, pancreas, kidneys, spleen, gallbladder, and gastrointestinal tract. Ultrasound contrast agents (UCAs) act as true blood-pool tracers, providing unique, characteristic contrast washin/washout kinetics and enhancement patterns that can be used to characterize various lesions that may not be detected by other imaging modalities.

CEUS has several advantages over CE-computed tomography (CECT) and CE-magnetic resonance imaging (CEMRI). In addition to having a lack of exposure to ionizing radiation, CEUS can be used in patients with renal and hepatic insufficiency and in pregnant women. The cost of CEUS is significantly lower than CECT and CEMRI, and CEUS is portable and thus can be performed at the bedside. Education in regard to the indications and benefits of CEUS of the abdomen is greatly needed to increase patient safety and lower
healthcare resource utilization.

Objectives

After completing this activity, participants should be better able to:

• Summarize indications, recommendations, and clinical trials demonstrating the clinical utility of CEUS of the
  abdomen, including the liver, pancreas, kidneys, spleen, gallbladder and biliary tree, and gastrointestinal tract
• Explain the fundamental physics of CEUS of the abdomen
• Interpret the safety, efficacy, and pharmacoeconomics of CEUS of the abdomen

Target Audience

This activity is designed for radiologists, sonographers, emergency department physicians, radiology nurses, and other healthcare professionals to provide them with medically relevant education on the role of contrast-enhanced ultrasound (CEUS) of the abdomen in the diagnosis and therapy decision-making for diseases of the liver, pancreas, kidneys, spleen, gallbladder and biliary tree, and gastrointestinal tract.

Accreditation

This SDMS CME activity has been planned and submitted for approval of 1.00 hour of SDMS CME Credit Category AB by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 07/14/2025 | Expiration Date 07/14/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its webinar activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Richard G. Barr, MD, PhD

Professor of Radiology
Northeast Ohio Medical University
Director, Southwoods Imaging
Department of Radiology
Surgical Hospital at Southwoods
Youngstown, Ohio

Edward G. Grant, MD, FACR

Professor and Chairman
Department of Radiology
Keck Hospital of USC
USC Norris Comprehensive Cancer Center
University of Southern California
Los Angeles, California

PDF Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “Use and Effectiveness of Contrast Enhanced Ultrasound (CEUS) for Echocardiography” discusses a practical overview of UEA imaging principles, understanding UEA quantification, and reviewing the developing technology with potential clinical applications tailored to individual patients. The purpose of this webinar is to provide Sonographers, Imaging Nurses, Administrators, Researchers, and Others with current clinical data to make informed decisions in their clinical settings.

Objectives

1. Discuss indications for UEA use and evidence base for efficacy in practice.
2. Identify how best to optimize image quality and promote appropriate UEA use in the echocardiography laboratory.
3. Review updated literature regarding the contemporary safety of UEAs and best practices for the use of UEAs in echocardiography laboratories.

Target Audience

The content of this SDMS CME symposium is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This SDMS CME activity has been planned and submitted for approval of .75 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 07/02/2025 | Expiration Date 07/02/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its webinar activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Jordan B. Strom, MD, MSc,
FACC, FASE

Medical Director, Echocardiography Laboratory,
Division of Cardiovascular Medicine,
Beth Israel Deaconess Medical Center
Associate Professor of Medicine, Harvard Medical School,
Boston, MA

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This course will address the ongoing challenge of colorectal cancer (CRC), the second leading cause of cancer-related death in the United States, and the continued gap in screening adherence. Early detection and removal of precancerous lesions significantly reduce mortality, highlighting the importance of accessible screening strategies. While optical colonoscopy remains the most widely used visual modality, its invasive nature may limit patient participation. This session will explore Computed Tomography Colonography (CTC) as a noninvasive, efficient alternative that may improve screening uptake and expand access to effective CRC detection.

Objectives

After completing this activity, participants should be better able to:

• Review current guidelines and recommendations for CRC screening
• Discuss the relative advantages and disadvantages of different CRC screening methods—with a focus on comparing OC vs. CTC
• Describe CTC procedures and summarize how to implement a successful CRC screening program

Target Audience

The content of this CE webinar is intended for technologists and other healthcare professionals involved with CRC screening.

Accreditation

This activity has been approved for .75 hours of Category A CE Credit by The International Society for MR Radiographers & Technologists (ISMRT). This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a live seminar/meeting or self-learning activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 03/11/2026 | Expiration Date 03/11/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CE activity. The planner has nothing to disclose.

Faculty

Judy Yee, MD, FACR

Professor and University Chair
Department of Radiology
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, New York

Kevin J. Chang, MD, FACR, FSAR

Director of MRI
Department of Radiology
Associate Professor of Radiology
Boston University School of Medicine
Boston, Massachusetts
Adjunct Associate Professor of Diagnostic Imaging
The Warren Alpert Medical School of Brown University
Providence, Rhode Island

Perry J. Pickhardt, MD

Professor of Radiology
Chief, Gastrointestinal Imaging
University of Wisconsin
School of Medicine & Public Health
Madison, Wisconsin

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “Basics of Bubbles: CEUS for Echocardiography and Implications for your lab” discusses a practical overview of UEA imaging principles, understanding UEA quantification, and reviewing the developing technology with potential clinical applications tailored to individual patients. The purpose of this webinar is to provide Sonographers, Imaging Nurses, Administrators, Researchers, and Others with current clinical data to make informed decisions in their clinical settings.

Objectives

• Review the basics of UEAs and the brands of UEA available in the United States
• Discuss indications for UEA use and evidence base for efficacy in practice
• Understand the best practices for the use of UEAs in echocardiography laboratories and the role of decision aides

Target Audience

The content of this SDMS CME symposium is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This SDMS CME activity has been planned and submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 06/23/2025 | Expiration Date 06/23/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its webinar activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Jordan B. Strom, MD, MSc,
FACC, FASE

Medical Director, Echocardiography Laboratory,
Division of Cardiovascular Medicine,
Beth Israel Deaconess Medical Center
Associate Professor of Medicine, Harvard Medical School,
Boston, MA

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “Use and Effectiveness of Contrast Enhanced Ultrasound (CEUS) for Echocardiography” discusses a practical overview of UEA imaging principles, understanding UEA quantification, and reviewing the developing technology with potential clinical applications tailored to individual patients. The purpose of this webinar is to provide Sonographers, Imaging Nurses, Administrators, Researchers, and Others with current clinical data to make informed decisions in their clinical settings.

Objectives

1. Discuss indications for UEA use and evidence base for efficacy in practice.
2. Identify how best to optimize image quality and promote appropriate UEA use in the echocardiography laboratory.
3. Review updated literature regarding the contemporary safety of UEAs and best practices for the use of UEAs in echocardiography laboratories.

Target Audience

The content of this CME webinar is intended for healthcare professionals including Radiologists, Cardiologists, and Other Physicians, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of Northwest Imaging Forums. NWIF is accredited by the ACCME to provide CME for physicians. NWIF designates this educational activity for .75 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity for which they attended.

Nurses may claim credit for activities approved for AMA PRA Category 1 Credits ™ in most states, for up to 50% of the nursing requirement for recertification. This course is designated for .75 AMA PRA Category 1 Credits ™.

Release Date: 05/05/2025 | Expiration Date 07/02/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its live activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Jordan B. Strom, MD, MSc,
FACC, FASE

Medical Director, Echocardiography Laboratory,
Division of Cardiovascular Medicine,
Beth Israel Deaconess Medical Center
Associate Professor of Medicine, Harvard Medical School,
Boston, MA

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “Basics of Bubbles: CEUS for Echocardiography and Implications for your lab” discusses a practical overview of UEA imaging principles, understanding UEA quantification, and reviewing the developing technology with potential clinical applications tailored to individual patients. The purpose of this webinar is to provide Sonographers, Imaging Nurses, Administrators, Researchers, and Others with current clinical data to make informed decisions in their clinical settings.

Objectives

• Review the basics of UEAs and the brands of UEA available in the United States
• Discuss indications for UEA use and evidence base for efficacy in practice
• Understand the best practices for the use of UEAs in echocardiography laboratories and the role of decision aides

Target Audience

The content of this CME webinar is intended for healthcare professionals including Radiologists, Cardiologists, and Other Physicians, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of Northwest Imaging Forums. NWIF is accredited by the ACCME to provide CME for physicians. NWIF designates this educational activity for 1.0 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity for which they attended.

Nurses may claim credit for activities approved for AMA PRA Category 1 Credits ™ in most states, for up to 50% of the nursing requirement for recertification. This course is designated for 1.0 AMA PRA Category 1 Credits ™.

Release Date: 04/23/2025 | Expiration Date 06/23/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its live activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Jordan B. Strom, MD, MSc,
FACC, FASE

Medical Director, Echocardiography Laboratory,
Division of Cardiovascular Medicine,
Beth Israel Deaconess Medical Center
Associate Professor of Medicine, Harvard Medical School,
Boston, MA

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

2025 Updates Based on Recommended Topics from the ACR

Description
Objectives
Sample
Description

This 1 hour comprehensive course is designed for medical professionals requiring Level 1 certification for working within the MR Environment. The course explains what the American College of Radiology (ACR) is and its role in creating guidelines for medical facilities. All of the various roles for medical staff will be discussed with an emphasis on Level 1 roles and responsibilities. MR Zoning and its importance along with reasoning for controlled access into various areas of MR will be defined. The importance of MR Screening of both patients and medical professionals will be discussed. Finally, the difference between near incidents and actual incidents will be differentiated and examples of MR Safety accidents will be reviewed.

Objectives

• State what the American College of Radiology (ACR) is and their Guidelines
• Define roles and responsibilities with a concentration on Level 1 personnel
• Create an understanding of MR zoning and controlled access into Zone III
• Explain the importance of MR Screening of all staff and patients
• Inform Level 1 concerns for MR Safety as related to patients and personnel
• Show examples of MR Safety incidents

Sample

Sample handout:   MR Safety Level 1 Personnel Sample

Course Material MR Safety Level 1 Personnel Handout

Description/Statement of Need
Objectives
Target Audience
Accreditation
Faculty
Description/Statement of Need

The Ultrasound community is challenged with maintaining current knowledge of trends and advances that could impact decision-making. The goal of this roundtable will be to discuss clinical care topics, such as formulary, storage, use, and dilution practices utilizing three healthcare professionals. Additionally, this panel will discuss the feasibility and value of UEAs, and convey key information related to how to efficiently and safely use these UEAs in current clinical care.

Objectives

• To understand strategies to reduce the risk of adverse reactions to ultrasound enhancing agents.
• Perform proper administration of various ultrasound enhancing agents.
• How to properly assemble/ prepare the various ultrasound enhancing agents.
• To understand best practices for safe and appropriate use of ultrasound enhancing agents in echocardiography laboratories.
• To recognize the value and appropriate techniques for dilution of ultrasound enhancing agents to improve image quality and mitigate side effects.

Target Audience

The content of this SDMS CME webinar is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This program has been submitted for approval of 1.50 hours of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 01/20/2026 | Expiration Date 01/20/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Yvette Carvallo, RDCS, RVS, CCT, FASE

Overlook Medical Center
Atlantic Health System
Summit, New Jersey

Linda D. Gillam, MD, MPH, MACC, FAHA

Chair, Department of Cardiovascular Medicine
Medical Director, Cardiovascular Service Line
Morristown Medical Center / Atlantic Health System
Professor of Medicine, Sidney Kimmel Medical College
at Thomas Jefferson University

Jordan B. Strom, MD, MSc, FACC, FASE

Director, Echocardiography Laboratory
Division of Cardiovascular Medicine
Beth Israel Deaconess Medical Center
Associate Professor of Medicine
Harvard Medical School, Boston, MA

Ed Kent, B.S. Pharm., R.Ph.

Integrated Health Systems
Pharmacy Services and Diagnostic Imaging
Formulary Optimization
Post Falls, Idaho

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description/Statement of Need
Objectives
Target Audience
Accreditation
Faculty
Disclosure
Description/Statement of Need

The Ultrasound community is challenged with maintaining current knowledge of trends and advances that could impact decision-making. The goal of this roundtable will be to discuss clinical care topics, such as formulary, storage, use, and dilution practices utilizing three healthcare professionals. Additionally, this panel will discuss the feasibility and value of UEAs, and convey key information related to how to efficiently and safely use these UEAs in current clinical care.

Objectives

• To understand strategies to reduce the risk of adverse reactions to ultrasound enhancing agents.
• Perform proper administration of various ultrasound enhancing agents.
• How to properly assemble/ prepare the various ultrasound enhancing agents.
• To understand best practices for safe and appropriate use of ultrasound enhancing agents in echocardiography laboratories.
• To recognize the value and appropriate techniques for dilution of ultrasound enhancing agents to improve image quality and mitigate side effects.

Target Audience

The content of this CME webinar is intended for healthcare professionals including Physicians, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the
Accreditation Council for Continuing Medical Education (ACCME). Northwest Imaging Forums (NWIF) is accredited by the ACCME to provide continuing medical education for physicians. NWIF designates this webinar for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 01/20/2026 | Expiration Date 01/20/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Yvette Carvallo, RDCS, RVS, CCT, FASE

Overlook Medical Center
Atlantic Health System
Summit, New Jersey

Linda D. Gillam, MD, MPH, MACC, FAHA

Chair, Department of Cardiovascular Medicine
Medical Director, Cardiovascular Service Line
Morristown Medical Center / Atlantic Health System
Professor of Medicine, Sidney Kimmel Medical College
at Thomas Jefferson University

Jordan B. Strom, MD, MSc, FACC, FASE

Director, Echocardiography Laboratory
Division of Cardiovascular Medicine
Beth Israel Deaconess Medical Center
Associate Professor of Medicine
Harvard Medical School, Boston, MA

Ed Kent, B.S. Pharm., R.Ph.

Integrated Health Systems
Pharmacy Services and Diagnostic Imaging
Formulary Optimization
Post Falls, Idaho

Disclosure

Yvette Carvallo, RDCS, RVS, CCT, FASE

Bracco Diagnostics – Speaker Honorarium

Lantheus Medical Imaging – Speaker Honorarium

Linda D. Gillam, MD, MPH, MACC, FAHA

Edwards Lifesciences – Advisory Board Member/Core Lab Contracts

Philips – Advisory Board Member

Medtronic – Advisory Board Member/Core Lab Contracts

Abbott – Core Lab Contracts

Jordan B. Strom, MD, MSc, FACC, FASE

NIH/NHLBI R01, NIH/NHLBI K23 – Grant Support

Edwards Lifesciences – Grant Support & Advisory Board

Ultromic – Grant Support & Advisory Board

Anumana – Grant Support

Lantheus – Grant Support

GE – Consulting

Philips – Consulting

Bracco – Consulting

EchoIQ – Advisory Board

JRC-DMS – Fiduciary

ICUS – Fiduciary

Ed Kent, B.S. Pharm., R.Ph.

Bracco Diagnostics – Consultant for MRI only

Vizient, Inc. – Consultant

*All financial relationships have been mitigated, the planner has nothing to disclose.

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

Description/Statement of Need
Objectives
Target Audience
Accreditation
Faculty
Disclosures
Description/Statement of Need

MRI continues to advance diagnostic precision, with gadolinium-based contrast agents (GBCAs) playing a critical role in enhancing image clarity. Gadopiclenol, a new high-relaxivity GBCA, offers improved diagnostic outcomes with potentially lower doses, making it essential for clinicians to understand its application in practice. There is a need to share experiences and insights on converting to Gadopiclenol for body, cardiac, and neuroradiology imaging to optimize its use. Additionally, understanding the safety and tolerability of this new agent is vital for its successful adoption. These presentations aim to equip healthcare professionals with the knowledge needed to improve patient care using this innovative contrast agent.

Objectives

• Understand the clinical benefits of Gadopiclenol
• Explore practical applications of Gadopiclenol in body, cardiac, and neuroradiology MRI
• Evaluate the safety and tolerability of Gadopiclenol
• Identify strategies to successfully integrate Gadopiclenol into clinical MRI protocols while maintaining patient safety and optimizing diagnostic outcomes.

Target Audience

The content of this CME webinar is intended for healthcare professionals including radiologists, other physicians, radiologic and imaging nurses, facility managers, researchers, and others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of Northwest Imaging Forums. NWIF is accredited by the ACCME to provide CME for physicians. NWIF designates this educational activity for 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity for which they attended.

Nurses may claim credit for activities approved for AMA PRA Category 1 Credits™ in most states, for up to 50% of the nursing requirement for recertification. This course is designated for 1.0 AMA PRA Category 1 Credits™.

Release Date: 03/23/2026 | Expires: 03/23/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, Northwest Imaging Forums, Inc. (NWIF) ensures balance, independence, objectivity, and scientific rigor in all its educational activities. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planners are required to disclose all financial relationships with ineligible companies within the last 24 months. All relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Rajan T. Gupta, MD

Vice Chair, Clinical Affairs, Professor of Radiology, Professor in Urology, Director of Imaging

Duke Cancer Institute Center for Prostate & Urologic Cancers

Durham, NC

Neil M. Rofsky, MD, MHA, FACR

The Dr. Charles M. and Marilyn Newman Professor

System Chair, Department of Diagnostic, Molecular and Interventional Radiology

Senior Associate Dean of Wellness and Coaching, Icahn School of Medicine

Mount Sinai Health Systems

New York, NY

Robert W. W. Biederman, MD, FACC, FAHA, FSCMR, FASA

Professor of Medicine, West Virginia University, Morgantown, WV

Professor of Bioengineering, Carnegie Mellon University, Pittsburgh, PA

Professor of Medicine, Medical University of South Carolina/Roper-Saint Francis Hospital, Charleston, SC

Emanuel Kanal, MD, FACR, FISMRM, MRMD/SE, AANG

Chief, Division of Emergency Radiology

Director, Magnetic Resonance Services

Professor of Radiology and Neuroradiology

University of Pittsburgh Medical Center

University of Pittsburgh School of Medicine

Pittsburgh, PA

Disclosures
Robert W. W. Biederman, MD, FACC, FAHA, FSCMR, FASA

Professor of Medicine, West Virginia University, Morgantown, WV;
Professor of Bioengineering, Carnegie Mellon University, Pittsburgh, PA;
Professor of Medicine, Medical University of South Carolina/Roper-Saint Francis Hospital, Charleston, SC

Disclosures:

• Kiniksa: Honorarium/Speaker
• Amgen: Honorarium/Speaker
• Bristol Meyers Squibb: Honorarium/Speaker
• Janssen: Honorarium/Speaker
• Lantheus: Honorarium/Speaker

Neil M. Rofsky, MD, MHA, FACR

The Dr. Charles M. and Marilyn Newman Professor; System Chair, Department of Diagnostic, Molecular and Interventional Radiology;
Senior Associate Dean of Wellness and Coaching, Icahn School of Medicine, Mount Sinai Health Systems, New York, NY

Disclosures:

• No financial relationship within the past 24 months

Emanuel Kanal, MD, FACR, FISMRM, MRMD/SE, AANG

Chief, Division of Emergency Radiology; Director, Magnetic Resonance Services;
Professor of Radiology and Neuroradiology, University of Pittsburgh Medical Center, Pittsburgh, PA

Disclosures:

• No financial relationship within the past 24 months

Rajan T. Gupta, MD

Vice Chair, Clinical Affairs; Professor of Radiology; Professor in Urology;
Director of Imaging, Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC

Disclosures:

• Bard: Consultant
• Bayer Pharma AG: Consultant & Speakers Bureau
• Bracco Diagnostics: Consultant
• Philips: Consultant
• Quibim: Consultant
• RoClub: Consultant

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

2025 Updates Based on Recommended Topics from the ACR

Description
Objectives
Target Audience
Accreditation
Sample
Description

This MR safety video (approximately 50 minutes in length) is produced specifically for MR Level 2 Personnel as defined by the ACR Guidance Document on MR Safe Practices: 2013. The major topics covered in this video include: • Personnel designation • MR safety zones and access control • Static field • Gradient (time-varying) magnetic fields • Radio frequency (RF) fields • Spatial gradient fields • Patients with implants and/or devices • Labeling • Conditions of use (including B1+rms) • Managing patient warming • Preventing thermal injuries • Patient and non-patient screening • Quench • Medical emergencies in the MRI environment • Managing the claustrophobic or anxious patient This video program is intended to satisfy annual education requirements.

Please Note: This activity was previously offered within a combined CE Module and cannot be used again in this or any subsequent biennium if completed previously. Additionally, this activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.  In other words if you received credit for this course last year and you are not in a new biennium, you can not take this course for credit.

Objectives

• Define Level 1 and Level 2 MR personnel
• Define MR safety Zones III and IV
• Describe the procedures and documentation associated with screening non-MR personnel
• Describe the recommendations of both the ACR and Joint Commission with regard to screening patients
• Describe the importance of patients being dressed in MR appropriate attire prior to undergoing and MR procedure
• Describe how to minimize the risk to patients with regard to RF burns
• Name several methods to manage SAR during an MR procedure
• Describe the importance of monitoring patients and how to prepare for medical emergencies
• Name and describe the current labeling terminology for implants and devices
• Describe safety issues related to a quench
• Name the major acute and chronic gadolinium-based contrast media adverse events
• Describe techniques which can minimize patient anxiety

Target Audience

The content of this Contrast Enhanced MRI Program is intended for healthcare professionals who work in the MRI environment. These individuals include MRI Technologists, Imaging Nurses, MRI Researchers, and Others.

Accreditation

This program has been approved for 1.0 hour of Category A CE credit as designated by the Society for MR Radiographers & Technologists (SMRT) RCEEM. Please Note: This activity was previously offered within a combined CE Module and cannot be used again in this or any subsequent biennium if completed previously. Additionally, this activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 02/26/2024 | Expiration Date 02/27/2027

Sample

Description
Objectives
Target Audience
Accreditation
Faculty
Description

Ultrasound enhancing agents (UEAs) are increasingly becoming essential tools to enhance diagnostic accuracy in pediatric ultrasound and improve treatment outcomes, especially in cases that present technical challenges. Given the unique anatomical and physiological considerations in children, healthcare professionals in the pediatric field must stay current with advancements in UEA applications that can influence clinical decision-making. In this webinar, faculty will discuss the feasibility, value, and safety of UEAs in pediatric clinical settings, offering insights into how these agents can be used effectively in day-to-day care.

Objectives

• State the approved indications for contrast-enhanced ultrasound (CEUS) in children.
• Understand the technique for performing intravenous CEUS for focal liver lesions.
• Describe the technique for performing contrast-enhanced voiding urosonography (ceVUS).

Target Audience

The content of this SDMS CME symposium is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This program has been submitted for approval of .75 hour of SDMS CME Credit Category PE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 04/28/2026 | Expires 04/28/2027

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the SDMS CME activity. The planner has nothing to disclose.

Faculty

Jeannie Kwon, M.D.

Professor of Radiology
Division Chief, Pediatric Radiology UTSW
Chief Radiology Officer
Children’s Health
Dallas, TX

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.

We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

The use of ultrasound-enhancing agents (UEAs) in the practice of contrast echocardiography is now considered an essential component of a state-of-the-art echocardiography laboratory. Education on the appropriate use of UEAs to improve quantitative measurements of LV size and function, to detect regional dysfunction at rest and during stress, and to detect LV cavity abnormalities (thrombus, masses, hypertrophic cardiomyopathies, etc.) are necessary & their value to patient care needs to be reinforced. While didactic lectures are effective for teaching the impact of UEAs on patient care, the major clinical obstacle to the clinical adoption of contrast echocardiography is unfamiliarity with a variety of components. This IV access video allows for familiarity and learning so diagnostic imaging can be improved and patient care can be enhanced.

Objectives

• Introduction to prepare you for any type of IV or Agent administration training Types of agents & how to administer
• Challenges and benefits of implementing a sonographer agent administration & IV insertion program
• Pitfalls of IV insertion and solutions
• How to insert an IV
• How to remove an IV

Target Audience

The content of this SDMS CME symposium is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This program has been approved for .5 hours of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 11/17/2025 | Expiration Date 11/17/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Jessica Stout BS, RDCS, FASE

Technical Director, Echocardiography Laboratory, Beth Israel Deaconess Medical Center

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.

We are grateful to our faculty for their expertise and are privileged to work with them.

Description
Objectives
Target Audience
Accreditation
Faculty
Description

The use of ultrasound-enhancing agents (UEAs) in the practice of ultrasound imaging has become an indispensable clinical tool to improve image quality. Education on the appropriate use of UEAs to improve quantitative measurements of LV size and function, to detect regional dysfunction at rest and during stress, and to detect LV cavity abnormalities (thrombus, masses, hypertrophic cardiomyopathies, etc.) are necessary & their value to patient care needs to be reinforced. This webinar will focus in how to administer UEAs with a focus on abdominal ultrasound.

Objectives

• Introduction to prepare you for any type of IV or Agent administration training Types of agents & how to administer
• Challenges and benefits of implementing a sonographer agent administration & IV insertion program
• Pitfalls of IV insertion and solutions
• How to insert an IV
• How to remove an IV
• Why sonographers (with case examples)

Target Audience

The content of this SDMS CME symposium is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This program has been submitted for approval of 1.00 hours of SDMS CME Credit Category AB by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 11/17/2025 | Expiration Date 11/17/2026

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence,
objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose all relevant financial relationships with ineligible companies. Any relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose

Faculty

Christine Merrill, BSc, CRGS, CRVS, RDMS, RVT

Sonographer, Department of Radiology
University of Calgary
Calgary, AB Canada

Maria Stanczak, MS, RDMS, RVT, R.T(R)(M)

Assistant Professor and Vascular Sonography Clinical Coordinator
Thomas Jefferson University

Description
Target Audience
Accreditation
Sample
Description

This video is designed to assist sites in providing MR safety education for non- MRI personnel. The video addresses the importance of access restrictions to the MRI environment and MR safety screening for patients and support personnel.

Target Audience

Specifically designed for MR departments to use as an education tool for all hospital staff (ie non-MR personnel).

Accreditation

No-Accreditation

Sample

Description
Accreditation
Description

This video is designed to assist sites in providing MR safety training for first responders (in particular firefighters and police officers).  The main focus is on the dangers associated with the static field and quenching the magnet.  Importance of MRI personnel control of the environment is also emphasized.  

Accreditation

There is no accreditation for this video.

Description Objectives Target Audience Accreditation Sample Description

This MR safety video (approximately 50 minutes in length) is produced specifically for MR Level 2 Personnel as defined by the ACR Guidance Document on MR Safe Practices: 2013. The major topics covered in this video include:

• Personnel designation
• MR safety zones and access control
• Static field • Gradient (time-varying) magnetic fields
• Radio frequency (RF) fields
• Spatial gradient fields
• Patients with implants and/or devices
• Labeling
• Conditions of use (including B1+rms)
• Managing patient warming
• Preventing thermal injuries
• Patient and non-patient screening
• Quench
• Medical emergencies in the MRI environment
• Managing the claustrophobic or anxious patient

This video program is intended to satisfy annual education requirements

Objectives

• Define Level 1 and Level 2 MR personnel
• Define MR safety Zones III and IV
• Describe the procedures and documentation associated with screening non-MR personnel
• Describe the recommendations of both the ACR and Joint Commission with regard to screening patients
• Describe the importance of patients being dressed in MR appropriate attire prior to undergoing and MR procedure
• Describe how to minimize the risk to patients with regard to RF burns
• Name several methods to manage SAR during an MR procedure
• Describe the importance of monitoring patients and how to prepare for medical emergencies
• Name and describe the current labeling terminology for implants and devices
• Describe safety issues related to a quench
• Name the major acute and chronic gadolinium-based contrast media adverse events
• Describe techniques which can minimize patient anxiety

Target Audience

The content of this Contrast Enhanced MRI Program is intended for healthcare professionals who work in the MRI environment. These individuals include MRI Technologists, Imaging Nurses, MRI Researchers, and Others.

Accreditation

This program has no Category A CE credit assigned.

Sample

Sample Handout: MR Safety Level 2 Personnel Sample

Description
Objectives
Target Audience
Accreditation
Sample
Description

The MRI Registry Prep series is authored by Bill Faulkner, a well-known MRI consultant, author and MRI educator.   Topics in this series include: MR Hardware, Safety, Basic Principles of MRI, MR Image Contrast, Pulse Sequences, MR Data Acquisition, Imaging Options and Image Quality, MRA, Diffusion and Perfusion.  In addition, This MR Registry Prep series consists of 6 detailed videos, designed for the MR Technologist who are studying for the MR Certification Exam.  This series will cover the majority of physics-based topics that are on the MR Certification Exam. The viewer must achieve a score of 75% on all quizzes and view all videos to receive a certificate of completion.

MR Registry Prep Series Topics include:

• MR Hardware
• MR Safety
• Basic MR Principles
• Relaxation and MR Image Contrast
• Pulse Sequences
• MR Data Acquisition
• Imaging Options
• MR Image Quality
• Formulas and Calculations
• MRA
• Diffusion and Perfusion

Objectives

The series objective is to provide the participant with basic knowledge as it pertains to clinical MRI, in addition to helping them prepare to sit for the MRI certification exam.

Target Audience

• Technologists interested in MRI.
• Technologists who have never had any formal education in MRI principles.
• Molecular Imaging Technologists or CT Technologists who may be cross-training into MRI.
• Technologists who are preparing for the ARRT or ARMRIT MR certification exams.

Accreditation

This program has been approved for 6.0 hour of Category A CE credit as designated by the International Society for MR Radiographers & Technologists (ISMRT) RCEEM. 

Please Note:  If This activity was previously offered within a combined CE Module it cannot be used again in this or any subsequent biennium. Additionally, this activity may be available in multiple formats or from different sponsors.  ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 07/07/2025 | Expiration Date 07/07/2027

Sample